Casing, Villano G.

HRN: 22-07-44  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2022
MUPIROCIN 2%, 15G (TUBE)
10/18/2022
10/25/2022
TOPICAL
1mg
BID
Erythematous And Ulcerative Wound
Waiting Final Action 
10/18/2022
CEFTRIAXONE 1G (VIAL)
10/18/2022
10/24/2022
IVTT
2g
Q24
Erythematous And Ulcerative Wound With Purulent Discharges
Waiting Final Action 
10/21/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/21/2022
10/27/2022
IVT
4.5g
Q6
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: